<p>MUMBAI (Reuters) – Indian drugmaker <span>Piramal Healthcare</span> has concluded to buy a U.S.-based medical information provider for $635 million to boost <span>research and development</span>, a association pronounced on Wednesday, a month after it acquired a new molecules multiplication of Germany’s Bayer’s.</p>
<p> Mumbai-based <span>Piramal</span> has been looking to enhance a RD portfolio after it sole a formulations business to U.S.-based <span>Abbott Laboratories</span> for $3.72 billion in 2010.</p>
<p> The association aims to tighten a merger of <span>Decision Resources Group</span> (DRG), formed in <span>Burlington, Massachusetts</span>, by a finish of Jun 30. The unit, with a group of about 300 analysts, is approaching to move in revenues of $160 million in 2012.</p>
<p> Piramal is perplexing to concentration on grass-r...
0 comments
Post a Comment